Diabetes diagnoses are climbing, with about 37,000 adults diagnosed in Indiana every year, and doctors caution they are ...

Eli Lilly's experimental obesity therapy bimagrumab drew mixed reactions from Wall Street after the company recently ...

The coroner's office identified the victim as 16-year-old Rasheed Mills. On Tuesday, CPD, along with the help of the Youth ...

Classically, the diagnosis of type 1 diabetes comes after a patient presents with unexplained weight loss, extreme thirst and frequent urination and a lab test reveals off-the-charts blood glucose ...

Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

The newly launched South African Blood Regulatory (SABR) dataset reveals how genetic variation influences blood traits and ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...